HS
XLRN

HighVista Strategies’s Acceleron Pharma XLRN Stock Holding History

HighVista Strategies’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-9,777
Closed -$1.68M – 141
2021
Q3 		$1.68M Buy
9,777
+3,600
+58% +$471K 1.11% 14
2021
Q2 		$775K Buy
+6,177
New +$779K 0.55% 57

HighVista Strategies's XLRN Position: Q4 2021 in Review

HighVista Strategies sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 9,777 shares — an estimated $1.68M sold.

HighVista Strategies first reported a position in XLRN in Q2 2021 and held it in 2 quarters. The position peaked at $1.68M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • HighVista Strategies reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • HighVista Strategies sold 9,777 Acceleron Pharma shares in Q4 2021, an estimated $1.68M.
  • HighVista Strategies first reported a position in Acceleron Pharma in Q2 2021 and held it in 2 quarters.
  • HighVista Strategies's Acceleron Pharma position peaked at $1.68M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on HighVista Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.